Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer

BACKGROUND: We conducted comprehensive clinical and molecular characterization of claudin 18.2 expression (CLDN18.2) in advanced gastric or gastroesophageal junction cancer (GC/GEJC). PATIENTS AND METHODS: Patients with advanced GC/GEJC who received systemic chemotherapy from October 2015 to Decembe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Y., Kawazoe, A., Mishima, S., Nakamura, Y., Kotani, D., Kuboki, Y., Bando, H., Kojima, T., Doi, T., Yoshino, T., Kuwata, T., Shitara, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024138/
https://www.ncbi.nlm.nih.gov/pubmed/36610262
http://dx.doi.org/10.1016/j.esmoop.2022.100762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024138/
https://www.ncbi.nlm.nih.gov/pubmed/36610262
http://dx.doi.org/10.1016/j.esmoop.2022.100762

Ejemplares similares